RecruitingNot ApplicableNCT06719739

Functional IOL Implantation in Patients with Epiretinal Membrane

Clinical Outcomes in Cataract Patients with Macular Epiretinal Membrane After Implantation of Functional Intraocular Lenses


Sponsor

Eye & ENT Hospital of Fudan University

Enrollment

90 participants

Start Date

Sep 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.


Eligibility

Min Age: 20 YearsMax Age: 90 Years

Inclusion Criteria4

  • Requirement for cataract extraction
  • Age \> 40 years
  • Axial length in 21mm to 25mm
  • ERM

Exclusion Criteria5

  • Residual corneal astigmatism \> 1.0 D
  • Amblyopia
  • Previous ocular surgery
  • Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects
  • Requirements for further ocular surgery (other than Nd:YAG capsulotomy) or retinal laser treatments during the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntraocular lens implantation

Cataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.


Locations(2)

Eye and Ear, Nose, and Throat Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Shanghai Heping Eye Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06719739


Related Trials